John Freund (business executive)

Last updated
John Freund
John Freund.jpg
Alma mater Harvard University
Occupation(s)Founder and CEO of Skyline Ventures
Website www.skylineventures.com/team/john_freund.asp

John Freund is an American satirist and business executive. [1] [2] Freund and collaborator David Porter created the 1981 satirical poster Bedtime for Brezhnev [3] [4] [5] and co-authored the 1982 satirical book The Official MBA Handbook or How to Succeed in Business Without a Harvard MBA, [1] which spent 16 weeks on the New York Times bestseller list. [6] [7] Freund is the co-founder of Intuitive Surgical, [8] and the co-founder and former CEO of Arixa Pharmaceuticals. [9] He founded Skyline Ventures in 1997. [2]

Contents

Early life and education

Freund grew up in New York City. He graduated in 1975 with a B.A. from Harvard [1] where he was an editor of the Harvard Crimson . [10] [11] [12] After completing his B.A., Freund received an M.D. from Harvard Medical School. [13] He received an MBA from Harvard Business School in 1982. [1]

Career

Early career

In April 1981, while enrolled in Harvard Business School, Freund collaborated with classmate David Porter on a satirical poster for an imaginary movie called Bedtime for Brezhnev, featuring then-president Ronald Reagan. [3] [11] [5] The poster sold 275,000 copies, [14] and sales of Bedtime for Brezhnev earned them enough money to pay their second year tuition. [1] [5] In the 2021 book Cowboy Presidents, it was reported that Reagan was rumored to have loved the poster. [14] In 1982, Freund and David Porter co-authored the book The Official MBA Handbook or How to Succeed in Business Without a Harvard MBA, which they published under the pen names Jim Fisk and Robert Barron, respectively. [1] [15] The idea for the book first emerged when Freund and Porter approached the publisher Simon & Schuster to distribute Bedtime for Brezhnev, but the head of trade paperbacks instead suggested the pair write a satirical book about MBA's. [13] [16] At the time of the book's release, both men were preparing to start jobs with investment banks. [1] [11] The Official MBA Handbook or How to Succeed in Business Without a Harvard MBA spent 16 weeks on the New York Times bestseller list. [6] [7]

Medical startups

Freund began his business career as an investment banker in 1982 with Morgan Stanley. [6] In 1995, he co-founded the robotics startup Intuitive Surgical. [8] [17] Freund negotiated a licensing agreement with SRI for surgical technology that formed the nucleus of Intuitive Surgical's line of products. [2] Freund founded the venture capital firm Skyline Ventures in 1997 [2] [6] to invest in early-stage biotech. [18] Skyline was the lead investor in SI-Bone, a manufacturer of sacroiliac fusion implants that became commercially available in 2009. Following the investment, Freund joined the board of directors. [19] In 2016, [20] Freund co-founded the antibiotics manufacturer Arixa Pharmaceuticals and served as the company's CEO. [9] During Freund's tenure, the company developed ARX-1796, [21] an oral version of a β-lactamase inhibitor called avibactam that was previously only able to be administered intravenously. [22] Freund ran Arixa Pharmaceuticals as a virtual company, crediting low-overhead costs in the development of ARX-1796. [21] Arixa Pharmaceuticals was acquired by Pfizer in 2020. [9]

Personal life

In 1979, Freund married Linda Gray Sexton, a writer and the daughter of the Pulitzer prize winning poet Anne Sexton. [6] They divorced in 1998. [6] Freund is married to Linda S. Grais. [23]

Related Research Articles

<span class="mw-page-title-main">Business school</span> University-level institution teaching business administration

A business school is a higher education institution or professional school that teaches courses leading to degrees in business administration or management. A business school may also be referred to as school of management, management school, school of business administration, or colloquially b-school or biz school. A business school offers comprehensive education in various disciplines related to the world of business.

<span class="mw-page-title-main">Johnson & Johnson</span> American multinational pharmaceutical and consumer goods corporation

Johnson & Johnson (J&J) is an American multinational, pharmaceutical, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 40 on the 2023 Fortune 500 list of the largest United States corporations. Johnson & Johnson has a global workforce of approximately 130,000 employees who are led by the company’s current chairman and chief executive officer, Joaquin Duato.

<span class="mw-page-title-main">Chiron Corporation</span> American biotechnology firm (1981-2006)

Chiron Corporation was an American multinational biotechnology firm founded in 1981, based in Emeryville, California, that was acquired by Novartis on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines, and blood testing. Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit to Grifols and announced agreements for the sale of its vaccines unit to GlaxoSmithKline.

The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.

Gregory Stock is an American biophysicist, best-selling author, biotech entrepreneur, and the former director of the Program on Medicine, Technology and Society at UCLA’s School of Medicine. His interests lie in the scientific and evolutionary as well as ethical, social and political implications of today's revolutions in the life sciences and in information technology and computers.

<span class="mw-page-title-main">Intuitive Surgical</span> American Biotechnology Company

Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the NASDAQ-100 and S&P 500. As of 31 December 2021, Intuitive Surgical had an installed base of 6,730 da Vinci Surgical Systems, including 4,139 in the U.S., 1,199 in Europe, 1,050 in Asia, and 342 in the rest of the world.

Gordon M. Binder is an American businessman.

Primal Pictures is a business established in 1991 that provides 3D graphic renderings of human anatomy, built using real scan data from the Visible Human Project, for use by healthcare students, educators, and medical professionals. It operates the Anatomy.tv online platform. In one study, Anatomy.tv was deemed the greatest value in undergraduate anatomy education "since it had highest scores for effectiveness as well as the lowest scores for cost."

da Vinci Surgical System Robotic surgical system

The da Vinci Surgical System is a robotic surgical system that uses a minimally invasive surgical approach. The system is manufactured by the company Intuitive Surgical. The system is used for prostatectomies, increasingly for cardiac valve repair and for renal and gynecologic surgical procedures.

<span class="mw-page-title-main">Merck & Co.</span> American multinational pharmaceutical company

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of whom it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. It is one of the largest pharmaceutical companies in the world, generally ranking in the global top five by revenue.

Dr. Frederic Moll is a physician, medical device developer and entrepreneur, specializing in the field of medical robotics.

<span class="mw-page-title-main">Joseph Jimenez</span>

Joseph Jimenez is the former CEO of the Swiss pharmaceutical company Novartis.

<span class="mw-page-title-main">David Kalergis</span>

David Kalergis is an American life sciences entrepreneur and the co-founder, chairman and chief executive officer of Atelerix Life Sciences Inc., a Charlottesville, Virginia, U.S.-based biotechnology and pharmaceutical company developing novel treatments for the reversal of opioid induced respiratory depression. He co-founded the company in 2020 with Stephen Lewis, PhD, James Bates, MD/PhD, and Ben Gaston, MD.

<span class="mw-page-title-main">Robert A. Bradway</span> American businessman

Robert A. Bradway is an American businessman. He is the chairman and chief executive officer of Amgen.

<span class="mw-page-title-main">Robert Duggan (venture capitalist)</span> American businessman and prominent Scientologist

Robert W. Duggan is an American billionaire, entrepreneur, philanthropist, biotech executive, health care executive, educator, and human rights activist. He is the former CEO of biopharmaceutical company Pharmacyclics and was previously CEO of surgical systems maker Computer Motion from 1997 to 2003. Bob is the majority shareholder and is on the boards of directors of Pulse Biosciences and Summit Therapeutics, where he is also CEO.

<span class="mw-page-title-main">Henri Termeer</span>

Henri A. Termeer was a Dutch biotechnology executive and entrepreneur who is considered a pioneer in corporate strategy in the biotechnology industry for his tenure as CEO at Genzyme. Termeer created a business model adopted by many others in the biotech industry by garnering steep prices— mainly from insurers and government payers— for therapies for rare genetic disorders known as orphan diseases that mainly affect children. Genzyme uses biological processes to manufacture drugs that are not easily copied by generic-drug makers. The drugs are also protected by orphan drug acts in various countries which provides extensive protection from competition and ensures coverage by publicly funded insurers. As CEO of Genzyme from 1981 to 2011, he developed corporate strategies for growth including optimizing institutional embeddedness nurturing vast networks of influential groups and clusters: doctors, private equity, patient-groups, insurance, healthcare umbrella organizations, state and local government, and alumni. Termeer was "connected to 311 board members in 17 different organizations across 20 different industries" He has the legacy of being the "longest-serving CEO in the biotechnology industry.

<span class="mw-page-title-main">Hanmi Pharm</span> South Korean pharmaceutical company

Hanmi Pharm Co., Ltd. is a South Korean pharmaceutical company that is headquartered in Seoul.

Carol Elizabeth Reiley is an American business executive, computer scientist, and model. She is a pioneer in teleoperated and autonomous robot systems in surgery, space exploration, disaster rescue, and self-driving cars. Reiley has worked at Intuitive Surgical, Lockheed Martin, and General Electric. She co-founded, invested in, and was president of Drive.ai, and is now CEO of a healthcare startup, a creative advisor for the San Francisco Symphony, and a brand ambassador for Guerlain Cosmetics. She is a published children's book author, the first female engineer on the cover of MAKE magazine, and is ranked by Forbes, Inc, and Quartz as a leading entrepreneur and influential scientist.

<span class="mw-page-title-main">Stéphane Bancel</span> French businessman

Stéphane Bancel is a French business executive. He is the chief executive officer (CEO) of the American pharmaceutical and biotechnology company Moderna, known for its COVID-19 vaccine. Before joining Moderna, Bancel was the CEO of French diagnostics company BioMérieux. Bancel is a partner at Flagship Pioneering, and has served on the boards of Indigo Agriculture, Boston's Museum of Science, and Qiagen. As of May 2023, his net worth was estimated at US$4.1 billion, owning about 8% of Moderna.

The Wyss Institute for Biologically Inspired Engineering is a cross-disciplinary research institute at Harvard University focused on bridging the gap between academia and industry by drawing inspiration from nature's design principles to solve challenges in health care and the environment. It is focused on the field of biologically inspired engineering to be distinct from bioengineering and biomedical engineering. The institute also has a focus on applications, intellectual property generation, and commercialization.

References

  1. 1 2 3 4 5 6 7 Ross, Nancy L. (12 September 1982). "Harvard Spoof Brings Degree of Success". Washington Post. Retrieved 31 May 2023.
  2. 1 2 3 4 Carlsen, Clifford (28 December 1997). "JMedical financier ready to operate after raising $23M". San Francisco Business Journal. Retrieved 31 May 2023.
  3. 1 2 "Poster Pranksters". Washington Post. No. 27 August 1981. Retrieved 30 May 2023.
  4. "TWO CAPITALIST TOOLS TELL US HOW TO SUCCEED IN BUSINESS WITHOUT REALLY TRYING TO GET AN MBA". People. No. 20 December 1982.
  5. 1 2 3 Heinzel, Ron S. (27 June 1982). "$5 Education May Supplant Harvard MBA". LA Times.
  6. 1 2 3 4 5 6 Berman, Jeffrey (3 September 2019). Mad Muse: The Mental Illness Memoir in a Writer's Life and Work. Emerald Publishing. pp. 190–198. ISBN   978-1-78973-807-0.
  7. 1 2 Tumulty, Karen (6 December 1982). "MBA Spoof Nothing to Laugh At". LA Times.
  8. 1 2 Tindera, Michela (14 February 2019). "BILLIONAIRES DAILY COVER Robot Wars: $60B Intuitive Surgical Dominated Its Market For 20 Years. Now Rivals Like Alphabet Are Moving In". Forbes. Retrieved 31 May 2023.
  9. 1 2 3 Vermes, Krystle (23 October 2020). "Could Arixa Pharmaceuticals' Lead Product Pave the Way for More Efficient Antibiotics?". BioSpace. Retrieved 26 May 2023.
  10. "J.G. Freund Weds Linda Sexton". New York Times. 20 August 1979. Retrieved 29 May 2023.
  11. 1 2 3 Gertson, Jill (11 July 1982). "Spoofing M.B.A. for big bucks". Providence Sunday Journal.
  12. "Linda Sexton, John Freund Set Wedding". New York Times. 15 July 1979. Retrieved 8 June 2023.
  13. 1 2 Walters, Ray (20 June 1982). "PAPERBACK TALK; Wits of the 80's". New York Times. Retrieved 31 May 2023.
  14. 1 2 Smith, David A. (2021). Cowboy Presidents: The Frontier Myth and U.S. Politics since 1900. University of Oklahoma Press. ISBN   978-0-8061-6848-7.
  15. Herman, Tom (14 April 2013). "It's Easy to File for an Extension". Wall Street Journal. Retrieved 30 May 2023.
  16. Kelly, John F. (12 September 1982). "Spoofing M.B.A for big bucks". The Baltimore Sun.
  17. Hockstein, N.G.; Gourin, C.G.; Faust, R.A.; Terris, D.J. (27 March 2017). "A history of robots: from science fiction to surgical robotics". Journal of Robotic Surgery. 1 (2): 113–118. doi:10.1007/s11701-007-0021-2. PMC   4247417 . PMID   25484946.
  18. Carroll, John (10 August 2011). "Skyline's Freund slams FDA's tougher stance on drug programs". Fierce Biotech. Retrieved 30 May 2023.
  19. Young, Robin (11 February 2022). "HOW IS IT POSSIBLE TO GET EXCLUSIVE REIMBURSEMENT STATUS?". Orthopedics This Week. Retrieved 4 July 2023.
  20. "SEC Schedule 14a" . Retrieved 7 June 2023.
  21. 1 2 Al Idrus, Amirah (22 October 2020). "Pfizer snaps up antibiotics maker Arixa and its oral Avycaz follow-up". Fierce Biotech. Retrieved 30 May 2023.
  22. Satyanarayana, Megha (16 December 2018). "The hunt for new antibiotics grows harder as resistance builds". Chemical and Engineering News. Retrieved 13 June 2023.
  23. "SEC Schedule 14a". sec.gov. Retrieved 14 July 2023.